EQUITY ISSUANCE AND REGISTRATION RIGHTS AGREEMENTEquity Issuance and Registration Rights Agreement • September 29th, 2025 • Dogwood Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2025 Company Industry JurisdictionThis Equity Issuance and Registration Rights Agreement (this “Agreement”) is dated as of September 29, 2025, by and between Dogwood Therapeutics, Inc., a Delaware corporation (the “Company”), Serpin Pharma, Inc., a Delaware corporation (“Serpin Pharma”) and Rejuvenation Labs, Inc., a Delaware corporation (“Rejuvenation Labs” and, together with Serpin Pharma, “Serpin”).
EQUITY ISSUANCE AND REGISTRATION RIGHTS AGREEMENTEquity Issuance and Registration Rights Agreement • September 29th, 2025 • Dogwood Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2025 Company Industry JurisdictionThis Equity Issuance and Registration Rights Agreement (this “Agreement”) is dated as of September 29, 2025, by and between Dogwood Therapeutics, Inc., a Delaware corporation (the “Company”), Serpin Pharma, Inc., a Delaware corporation (“Serpin Pharma”) and Rejuvenation Labs, Inc., a Delaware corporation (“Rejuvenation Labs” and, together with Serpin Pharma, “Serpin”).